[go: up one dir, main page]

NO913816D0 - Fremstilling av liposom- og lipidkompleksblandinger. - Google Patents

Fremstilling av liposom- og lipidkompleksblandinger.

Info

Publication number
NO913816D0
NO913816D0 NO1991913816A NO913816A NO913816D0 NO 913816 D0 NO913816 D0 NO 913816D0 NO 1991913816 A NO1991913816 A NO 1991913816A NO 913816 A NO913816 A NO 913816A NO 913816 D0 NO913816 D0 NO 913816D0
Authority
NO
Norway
Prior art keywords
compounds
liposome
aprotic solvent
liposom
preparation
Prior art date
Application number
NO1991913816A
Other languages
English (en)
Other versions
NO303205B1 (no
NO913816L (no
Inventor
Jr Francis C Szoka
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of NO913816D0 publication Critical patent/NO913816D0/no
Publication of NO913816L publication Critical patent/NO913816L/no
Publication of NO303205B1 publication Critical patent/NO303205B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO913816A 1989-03-31 1991-09-27 FremgangsmÕte for fremstilling av lipidkompleksoppslemming NO303205B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33260989A 1989-03-31 1989-03-31
US33405589A 1989-04-05 1989-04-05
PCT/US1990/001646 WO1990011780A1 (en) 1989-03-31 1990-03-28 Preparation of liposome and lipid complex compositions

Publications (3)

Publication Number Publication Date
NO913816D0 true NO913816D0 (no) 1991-09-27
NO913816L NO913816L (no) 1991-11-26
NO303205B1 NO303205B1 (no) 1998-06-15

Family

ID=26988293

Family Applications (1)

Application Number Title Priority Date Filing Date
NO913816A NO303205B1 (no) 1989-03-31 1991-09-27 FremgangsmÕte for fremstilling av lipidkompleksoppslemming

Country Status (12)

Country Link
EP (1) EP0467954B1 (no)
JP (1) JP2798302B2 (no)
AT (1) ATE137403T1 (no)
AU (1) AU638245B2 (no)
CA (1) CA2050679C (no)
DE (1) DE69026820T2 (no)
DK (1) DK0467954T3 (no)
ES (1) ES2087151T3 (no)
HK (1) HK1000912A1 (no)
HU (1) HU208070B (no)
NO (1) NO303205B1 (no)
WO (1) WO1990011780A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5178875A (en) * 1991-01-14 1993-01-12 The Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
JPH0363298A (ja) * 1989-07-31 1991-03-19 Green Cross Corp:The コロニー形成刺激因子・脂質複合体
FR2653015B1 (fr) * 1989-10-12 1993-10-29 Oreal Composition cosmetique ou pharmaceutique pour application topique contenant au moins un derive retinouide et au moins un derive de pyrimidine, son utilisation comme medicament et procede de traitement correspondant.
ATE176155T1 (de) 1990-11-16 1999-02-15 Nippon Shinyaku Co Ltd Injizierbare amphotericin b enthaltende dispersion
DE4238779A1 (de) * 1992-11-12 1994-05-19 Max Delbrueck Centrum Lyotrophe Mesophasen und ihre Anwendung in der Pharmazie, der Kosmetik und der Dermatologie
ES2154680T3 (es) 1993-07-08 2001-04-16 Liposome Co Inc Metodo para controlar el tamaño de los liposomas.
AU678609B2 (en) * 1993-09-29 1997-06-05 Gist-Brocades N.V. A novel antifungal composition
CA2223179A1 (en) * 1995-06-07 1996-12-19 Bob Dale Brown Phosphonic acid-based cationic lipids
AU773618B2 (en) * 1998-12-22 2004-05-27 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Water-insoluble drug delivery system
US6511676B1 (en) * 1999-11-05 2003-01-28 Teni Boulikas Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
JPWO2002034252A1 (ja) 2000-10-26 2004-03-04 千寿製薬株式会社 ジペプチジルアルデヒド誘導体含有医薬組成物
AU1999802A (en) * 2000-12-01 2002-06-11 Lawrence Boni Preparation of large liposomes by infusion into peg
IS6389A (is) * 2001-08-31 2003-03-03 Heraeus Kulzer Gmbh & Co. Kg Reynsla af sýklalyfjahúðun skrokka, sem í eru örholrými, og einnig af þannig húðuðum skrokkum og notkun þeirra
WO2008114274A1 (en) * 2007-03-19 2008-09-25 Fresenius Kabi Onclology Ltd. Proliposomal and liposomal compositions
WO2009064696A1 (en) * 2007-11-14 2009-05-22 The Regents Of The University Of California Sterol-modified amphiphilic lipids
EP2344198B1 (en) * 2008-09-27 2020-11-04 Jina Pharmaceuticals Inc. Lipid based pharmaceutical preparations for topical application
EP2594281B1 (en) * 2010-07-14 2019-08-28 Institute Of Materia Medica, Chinese Academy Of Medical Sciences Insulin-lipid complex, preparation method therefor, and preparation thereof
CA2962709C (en) 2014-08-04 2023-09-19 Zoneone Pharma, Inc. Remote loading of sparingly water-soluble drugs into lipid vesicles
CN113616798A (zh) * 2021-09-06 2021-11-09 天津农学院 一种甲苯咪唑脂质复合物、制备方法和应用
CN115177590A (zh) * 2022-04-20 2022-10-14 南昌大学抚州医学院 一种甲苯达唑类脂质体的制备方法及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
JPS60240634A (ja) 1984-05-08 1985-11-29 関　則雄 飲み干し容易なコツプ
US4619913A (en) * 1984-05-29 1986-10-28 Matrix Pharmaceuticals, Inc. Treatments employing drug-containing matrices for introduction into cellular lesion areas
AU598002B2 (en) * 1986-07-15 1990-06-14 Cilag Ltd. Method of preparing single bilayered liposomes
US4839175A (en) * 1986-07-28 1989-06-13 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
US4804539A (en) 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
US4812312A (en) * 1987-03-03 1989-03-14 Board Of Regents Of The University Of Texas System Liposome-incorporated nystatin
NZ223660A (en) * 1987-03-05 1990-11-27 Liposome Co Inc Low toxicity drug-lipid complexes; methods of making them; and method of determining their toxicity

Also Published As

Publication number Publication date
AU5434590A (en) 1990-11-05
HU903559D0 (en) 1991-12-30
DK0467954T3 (da) 1996-05-28
DE69026820T2 (de) 1996-11-28
JP2798302B2 (ja) 1998-09-17
WO1990011780A1 (en) 1990-10-18
CA2050679C (en) 1998-09-22
CA2050679A1 (en) 1990-10-01
DE69026820D1 (de) 1996-06-05
EP0467954A1 (en) 1992-01-29
EP0467954B1 (en) 1996-05-01
JPH04506207A (ja) 1992-10-29
HK1000912A1 (en) 1998-05-08
EP0467954A4 (en) 1992-06-03
ATE137403T1 (de) 1996-05-15
NO303205B1 (no) 1998-06-15
NO913816L (no) 1991-11-26
ES2087151T3 (es) 1996-07-16
HU208070B (en) 1993-08-30
HUT59818A (en) 1992-07-28
AU638245B2 (en) 1993-06-24

Similar Documents

Publication Publication Date Title
NO913816D0 (no) Fremstilling av liposom- og lipidkompleksblandinger.
DE3867866D1 (de) Liposomzubereitung und ihre herstellung.
CA1262093C (en) STEROID LIPOSOMES
ES2107668T3 (es) Liposomas, procedimiento para su preparacion y su uso en la elaboracion de un medicamento.
LU90717I2 (fr) Complexe citrate-doxorubicine encapsul- dans des liposomes
GR3020068T3 (en) Preparation of lipidic microparticles
NO172729C (no) Fremgangsmaate for fremstilling av en suspensjon av fosfolipidvesikler.
NO174833C (no) Fremgangsmåte for fremstilling av et injiserbart preparat
EP1419789A3 (en) Preparation of a lipid blend and a phospholipid suspension containing the lipid blend, and contrast agents based on these
DK544883A (da) Stabile plurilamellare vesikler
ATE139439T1 (de) Pharmazeutische formulierung und pharmazeutisches verfahren
ES8600931A1 (es) Un procedimiento para preparar una solucion acuosa que contiene una sustancia farmaceutica soluble en lipidos
CA2099771A1 (en) Liposomal-polyene preliposomal powder and method for its preparation
RU2000124317A (ru) Эритропоэтиновая липосомальная дисперсия
FI916120A0 (fi) Foerfarande foer framstaellning av vattenhaltiga liposomsuspensioner som innehaoller ett aktivt aemne.
DE69738416T2 (de) Liposomale zubereitungen von indolocarbazol-derivaten
ZA884513B (en) Drug emulsion
ATE112679T1 (de) Wässrige bereitung von liposomenzusammensetzungen.